International experts slam US college HbA1c guidance

Leading diabetes experts worldwide have criticised newly-published guidance on HbA1c targets by the American College of Physicians (ACP).

Professor Sophia Zoungas, president of the Australian Diabetes Society, is one of seven authors of an editorial that takes the college to task for recommending a relaxed target for HbA1c of 53-64mmol/L (7-8%) in most patients with type 2 diabetes.

Other ACP recommendations under fire include that consideration be given to reducing pharmacologic therapy in patients who achieve HbA1c levels less than 48mmol/L (6.5%), and that patients aged 80 or over